Yuka Maeda
University of Tsukuba(JP)Institute of Applied Biochemistry(JP)
Publications by Year
Research Areas
Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research
Most-Cited Works
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,863 cited
- → Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers(2016)868 cited
- → The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies(2020)795 cited
- → Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments(2022)777 cited
- → Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans(2013)611 cited
- → Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals(2014)204 cited
- Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.